Filing Details
- Accession Number:
- 0000904454-20-000090
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-29 18:02:58
- Reporting Period:
- 2020-01-27
- Accepted Time:
- 2020-01-29 18:02:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1590560 | Uniqure N.v. | QURE | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1716268 | Robert Gut | C/O Uniqure N.v. Paasheuvelweg 25A Amsterdam P7 1105BP | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2020-01-27 | 6,897 | $60.01 | 28,481 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2020-01-28 | 596 | $62.19 | 27,885 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
- As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units.
Billionaire Hedge Funds
